“Most users tolerate GLP-1 medications like Ozempic without serious oral health issues, but a subset experience notable side ...

Fox News senior medical analyst Dr. Marc Siegel joins 'Fox News Live' to discuss how tennis icon Serena Williams was able to ...

Anecdotal reports describe an unusual GLP-1 side effect some are calling "Ozempic vulva," which involves sagging skin, ...

Mounjaro and other GLP-1 drugs may lower cancer risk in obese patients, according to a new study. Read more here.

In this second part of a three-part of a video series, Kasey Raetz, Pharm.D., a PBMI Innovator, told MHE about leading the ...

Serena Williams opens up about losing over 31 pounds using GLP-1 medication, sharing how it enhanced her healthy lifestyle.

A study has found that adults with obesity taking GLP-1 receptor agonists may face significantly lower risk of developing certain cancers. The cohort study was led by researchers from the Indiana ...

Serena Williams has a new doubles partner. The 23-time Grand Slam tennis champion is working with Ro, speaking out about how she used the direct-to-patient telehealth company to access GLP-1s for ...

People taking GLP-1 agonists for diabetes have a significantly lower risk of developing dementia compared to those using metformin, a new study has found.

Explore the potential of GLP-1 receptor agonists for rheumatoid arthritis. Learn about their safety, benefits, and what to consider before starting these medications.

People taking GLP-1 medications had better-controlled asthma overall, though there was no difference in lung function compared to those not taking GLP-1s. The study suggests that GLP-1 drugs may ...

Glucagon-like peptide-1 (GLP-1) inhibitors have proven effective in preventing cardiovascular events, leading to experts promoting their use outside of care for diabetes.